Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV - Wikidata - awgldk - TriplyDB

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

http://www.wikidata.org/entity/Q37199661

about

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma.Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?Oncolytic virotherapy for head and neck cancer: current research and future developments.Copper transporters and chaperones: Their function on angiogenesis and cellular signalling.Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy.Synthesis and supramolecular assembly of 1,3-bis(1′-uracilyl)-2-propanone

P2860

Q26998111-DE76A55C-F38F-4034-8DDB-EDB127825D1F Q33566511-E3E85DF3-D501-4CCE-B843-D25A6CFA7225 Q35618563-2939AA41-3DE3-474E-89FB-EFDA52131B04 Q36020835-2336BA11-FDAD-48E8-A132-25F4EB7284B5 Q36664273-F1C1FFC5-D676-40B2-9590-E8EFF4FF4506 Q36849213-D0A8CFF8-003D-43DA-84EB-929C49224AE2 Q37316856-2A8DA09F-F36F-46BE-8F52-80D7642169FE Q38094806-3CD435C3-AD53-4D2F-9D44-B2C156A0729E Q38924562-6A0C3E9F-5168-4A41-9D99-AF7B1148D567 Q38942904-60F4C859-E8FB-4191-8DEC-1C882F2E56E0 Q39339386-69FFD495-E1DD-40A6-96A4-C42046C74E83 Q40498974-150B3F30-CFC5-4791-A6EC-E4D44747B800 Q52312118-3D83AD05-9E82-459F-8643-BCB7AC22099D Q58466742-74156884-7C48-4F3C-88FA-D6D7BBD126D1

P2860

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

http://www.wikidata.org/entity/Q37199661

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 July 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

@en

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

@nl

type

label

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

@en

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

@nl

prefLabel

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

@en

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

@nl

P1433

Q37199661-F5836CCC-DCCC-4D10-890C-A2B81F14F592

P1476

Q37199661-FC985567-B5FE-4A39-930D-E9DE378FAC6A

P2093

Q37199661-114E37A4-3E95-48B5-AC62-CCA3A42E25AB

Q37199661-13726982-82CD-4AA7-B1A6-8A4DEED1A806

Q37199661-1BE9B02A-42A2-4773-994C-F0BCF221CBCD

Q37199661-39BF782D-FD4B-414D-9E64-8F002803C87F

Q37199661-4EE08FA3-3B1E-4A5C-8177-FD9203365481

Q37199661-5BDDCC46-22EF-4692-9444-37050607E13E

Q37199661-5FA32FC6-E3BD-48EB-A8E1-9EE16E3D1B8D

Q37199661-71DF6D4E-23F3-4E15-9FE0-3BCADD39EFC6

Q37199661-7DFE3803-A27C-405A-A076-87C794F93CDF

Q37199661-85A44A96-5C4C-4EDF-AD19-E6C03BDECDEC

P2860

Q37199661-0B3A36C5-BB27-4D27-B91E-760C2182E4A6

Q37199661-119820EA-0FC1-454B-8127-07850231A806

Q37199661-121E46C3-72D8-4A55-9457-B8DDA7973D9D

Q37199661-155CA754-ABEA-4EA0-8935-0208B0339272

Q37199661-1748DF61-5161-4A67-B1F5-6566E4EEC884

Q37199661-18488EE6-BEDC-46ED-AC36-492DD55EE008

Q37199661-35621F76-7B51-44A4-A10A-20AE6AF84F0E

Q37199661-35AFDCA5-5F40-44B9-98DA-ED4FEC1E3837

Q37199661-3665E642-481F-4AE3-9AD5-A6C408ACF27B

Q37199661-39734E3C-3685-44CB-9F8C-1239A9AFF6AD

P304

Q37199661-94AEE7C1-C1F9-40FB-A578-4472DD5FD317

P31

Q37199661-3129DD32-0BC2-4A31-8B41-F03B451C6B94

P356

Q37199661-43683C33-9A2D-4068-8506-2114250E6686

P407

Q37199661-5A24253B-9C1A-414E-A1F6-5525F6CD5F13

P433

Q37199661-1A82631F-D6BF-475E-869C-663C0BB7BE46

P478

Q37199661-278F6906-8192-408B-8BD8-9DA9A229797B

P577

Q37199661-6D520A13-B8A0-4F91-8F55-73BC1A5F8CAC

P698

Q37199661-2CC68412-6ABE-4111-A937-4077DC2EA1D5

P932

Q37199661-AFD52142-8FAB-44B0-BAB0-4CE1B5B533F2

P356

1078-0432.CCR-12-0697

P1433

Clinical Cancer Research

P1476

Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV

@en

P2093

Amy Haseley

http://www.w3.org/2001/XMLSchema#string

Andrew P Mazar

http://www.w3.org/2001/XMLSchema#string

Anna Bratasz

http://www.w3.org/2001/XMLSchema#string

Azeem Kaka

http://www.w3.org/2001/XMLSchema#string

Balveen Kaur

http://www.w3.org/2001/XMLSchema#string

Christopher A Alvarez-Breckenridge

http://www.w3.org/2001/XMLSchema#string

E Antonio Chiocca

http://www.w3.org/2001/XMLSchema#string

Jason Pradarelli

http://www.w3.org/2001/XMLSchema#string

Jeffrey Wojton

http://www.w3.org/2001/XMLSchema#string

Ji Young Yoo

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells

Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates

Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Herpesvirus vectors for therapy of brain tumors.

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.

Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.

Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.

Mechanism of copper-mediated inactivation of herpes simplex virus.

P304

4931-4941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-12-0697

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22753591

http://www.w3.org/2001/XMLSchema#string

P932

3784008

http://www.w3.org/2001/XMLSchema#string